VENTANA PD-L1 (SP263) Assay

Companion diagnostics · class III · Until 14/02/2028

Registration no.
10287411301
Process no.
25351415911201704
Status
Until 14/02/2028
Device type
Companion diagnostics (COMPANION DIAGNOSTICS)
Risk class
III
Registration holder
ROCHE DIAGNÓSTICA BRASIL LTDA CNPJ 30.280.358/0001-86 · 1,784 registrations
Manufacturer
VENTANA MEDICAL SYSTEM, INC · United States
Published
14/02/2018
Valid until
14/02/2028
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other companion diagnostics registrations (8 in total, see all)

ProductClass HolderPublishedStatus
Anti-ALK (D5F3) Rabbit Monoclonal Primary
10287411745
III ROCHE DIAGNÓSTICA BRASIL LTDA 05/05/2025 Until 05/05/2035
VENTANA FOLR1 (FOLR-2.1) RxDx Assay
10287411743
III ROCHE DIAGNÓSTICA BRASIL LTDA 07/04/2025 Until 07/04/2035
HER2 FISH System
10337990030
III LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA. 02/07/2018 Until 23/11/2035
FAMÍLIA MARCADOR TUMORAL PD-L1
80000230077
III AGILENT TECHNOLOGIES BRASIL LTDA 03/04/2017 Until 19/12/2036
VENTANA PD-L1 (SP142) Assay
10287411206
III ROCHE DIAGNÓSTICA BRASIL LTDA 13/03/2017 Until 13/03/2037
HercepTest
80000230069
III AGILENT TECHNOLOGIES BRASIL LTDA 26/12/2016 Until 27/07/2035
Cobas® 4800 BRAF V600 Mutation Test
10287410968
III ROCHE DIAGNÓSTICA BRASIL LTDA 02/01/2012 Until 02/01/2037